 Nina Ma
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 5 | 2025 | 395 | 1.150 |
Why?
| | Osteoporosis | 4 | 2023 | 242 | 0.810 |
Why?
| | Carpal Bones | 1 | 2022 | 14 | 0.800 |
Why?
| | Osteolysis | 1 | 2022 | 18 | 0.790 |
Why?
| | Dietary Supplements | 3 | 2021 | 559 | 0.720 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2017 | 7 | 0.580 |
Why?
| | Bone and Bones | 3 | 2020 | 316 | 0.570 |
Why?
| | Fractures, Bone | 3 | 2023 | 420 | 0.570 |
Why?
| | Vitamin D Deficiency | 3 | 2025 | 184 | 0.570 |
Why?
| | Bone Diseases, Developmental | 1 | 2017 | 15 | 0.570 |
Why?
| | Bone Development | 1 | 2017 | 54 | 0.560 |
Why?
| | Bone Diseases, Metabolic | 3 | 2023 | 62 | 0.550 |
Why?
| | Infant Health | 1 | 2017 | 25 | 0.540 |
Why?
| | Scurvy | 1 | 2016 | 15 | 0.500 |
Why?
| | Genetic Association Studies | 1 | 2017 | 376 | 0.490 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2017 | 233 | 0.470 |
Why?
| | Food Preferences | 1 | 2016 | 119 | 0.460 |
Why?
| | Familial Hypophosphatemic Rickets | 2 | 2016 | 6 | 0.450 |
Why?
| | Congenital Hypothyroidism | 2 | 2012 | 11 | 0.430 |
Why?
| | Autistic Disorder | 1 | 2016 | 201 | 0.410 |
Why?
| | Optic Nerve Diseases | 2 | 2012 | 38 | 0.410 |
Why?
| | Bone Density | 7 | 2023 | 487 | 0.410 |
Why?
| | Rheumatology | 2 | 2023 | 120 | 0.380 |
Why?
| | Alkaline Phosphatase | 3 | 2020 | 148 | 0.350 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2009 | 20 | 0.320 |
Why?
| | Transcription Factors | 1 | 2017 | 1714 | 0.320 |
Why?
| | RNA Splice Sites | 1 | 2009 | 45 | 0.310 |
Why?
| | Hospitalization | 2 | 2017 | 2195 | 0.310 |
Why?
| | Receptors, Calcitriol | 1 | 2009 | 55 | 0.310 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2417 | 0.300 |
Why?
| | Hypophosphatemia | 2 | 2020 | 17 | 0.300 |
Why?
| | Gynecomastia | 1 | 2008 | 6 | 0.300 |
Why?
| | Thymus Gland | 1 | 2009 | 313 | 0.290 |
Why?
| | Mutation | 3 | 2022 | 3953 | 0.290 |
Why?
| | Infant Formula | 2 | 2020 | 75 | 0.290 |
Why?
| | Calcium | 3 | 2017 | 1197 | 0.290 |
Why?
| | Bacterial Infections | 1 | 2009 | 251 | 0.270 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 316 | 0.270 |
Why?
| | Puberty | 1 | 2008 | 146 | 0.270 |
Why?
| | Fractures, Multiple | 1 | 2025 | 6 | 0.240 |
Why?
| | Child | 13 | 2023 | 21968 | 0.220 |
Why?
| | Absorptiometry, Photon | 4 | 2023 | 253 | 0.220 |
Why?
| | Infant | 10 | 2025 | 9442 | 0.220 |
Why?
| | Child, Preschool | 9 | 2025 | 11069 | 0.220 |
Why?
| | Humans | 25 | 2025 | 136783 | 0.190 |
Why?
| | Phenotype | 2 | 2022 | 3199 | 0.190 |
Why?
| | Radiography | 2 | 2017 | 829 | 0.180 |
Why?
| | Spinal Fractures | 1 | 2022 | 84 | 0.180 |
Why?
| | T-Lymphocytes | 1 | 2009 | 1998 | 0.170 |
Why?
| | Mutation, Missense | 1 | 2022 | 338 | 0.170 |
Why?
| | Hypophosphatasia | 1 | 2020 | 3 | 0.170 |
Why?
| | Inservice Training | 1 | 2020 | 113 | 0.160 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 351 | 0.150 |
Why?
| | Male | 16 | 2025 | 67361 | 0.150 |
Why?
| | Spinal Fusion | 1 | 2022 | 251 | 0.150 |
Why?
| | Mentors | 1 | 2020 | 197 | 0.140 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2018 | 22 | 0.140 |
Why?
| | Interprofessional Relations | 1 | 2020 | 280 | 0.140 |
Why?
| | Mentoring | 1 | 2020 | 143 | 0.140 |
Why?
| | Female | 15 | 2025 | 72840 | 0.130 |
Why?
| | Syndrome | 1 | 2017 | 357 | 0.130 |
Why?
| | Multimorbidity | 1 | 2017 | 47 | 0.130 |
Why?
| | Adrenodoxin | 1 | 2016 | 1 | 0.130 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2016 | 17 | 0.130 |
Why?
| | Bone Diseases | 1 | 2017 | 62 | 0.130 |
Why?
| | Ascorbic Acid | 1 | 2016 | 126 | 0.120 |
Why?
| | Nutritional Status | 1 | 2018 | 344 | 0.120 |
Why?
| | Vitamins | 1 | 2016 | 177 | 0.110 |
Why?
| | Risk Factors | 4 | 2025 | 10331 | 0.110 |
Why?
| | Body Composition | 1 | 2018 | 677 | 0.110 |
Why?
| | Precision Medicine | 1 | 2018 | 426 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 611 | 0.110 |
Why?
| | Hyperparathyroidism, Secondary | 1 | 2012 | 12 | 0.100 |
Why?
| | Sunscreening Agents | 1 | 2012 | 23 | 0.100 |
Why?
| | Calcium, Dietary | 1 | 2012 | 57 | 0.100 |
Why?
| | Adolescent | 5 | 2018 | 21463 | 0.100 |
Why?
| | Thyrotropin | 1 | 2012 | 114 | 0.100 |
Why?
| | Diphosphonates | 1 | 2012 | 66 | 0.090 |
Why?
| | Bone Density Conservation Agents | 1 | 2012 | 80 | 0.090 |
Why?
| | Osteoporotic Fractures | 1 | 2012 | 61 | 0.090 |
Why?
| | Length of Stay | 1 | 2017 | 1208 | 0.090 |
Why?
| | Vision Disorders | 1 | 2012 | 141 | 0.090 |
Why?
| | Osteolysis, Essential | 1 | 2010 | 1 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 2068 | 0.090 |
Why?
| | Lymphangioma | 1 | 2010 | 7 | 0.090 |
Why?
| | United States | 4 | 2023 | 14660 | 0.080 |
Why?
| | Hyperprolactinemia | 1 | 2010 | 5 | 0.080 |
Why?
| | Thyroid Function Tests | 1 | 2010 | 14 | 0.080 |
Why?
| | Vision Tests | 1 | 2010 | 16 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 2145 | 0.080 |
Why?
| | Hypopituitarism | 1 | 2010 | 15 | 0.080 |
Why?
| | Phytohemagglutinins | 1 | 2009 | 30 | 0.080 |
Why?
| | Lymphopoiesis | 1 | 2009 | 26 | 0.080 |
Why?
| | Soft Tissue Neoplasms | 1 | 2010 | 114 | 0.080 |
Why?
| | Age Factors | 1 | 2017 | 3290 | 0.080 |
Why?
| | Endocrine System Diseases | 1 | 2009 | 35 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2017 | 3537 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2831 | 0.080 |
Why?
| | Glucocorticoids | 2 | 2023 | 596 | 0.080 |
Why?
| | Cell Count | 1 | 2009 | 321 | 0.080 |
Why?
| | DNA, Complementary | 1 | 2009 | 269 | 0.080 |
Why?
| | Homeostasis | 1 | 2012 | 618 | 0.080 |
Why?
| | Androgen-Insensitivity Syndrome | 1 | 2008 | 4 | 0.080 |
Why?
| | Diarrhea | 1 | 2009 | 183 | 0.070 |
Why?
| | Stem Cell Transplantation | 1 | 2009 | 177 | 0.070 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 400 | 0.070 |
Why?
| | Age of Onset | 1 | 2010 | 518 | 0.070 |
Why?
| | Exons | 1 | 2009 | 349 | 0.070 |
Why?
| | Exercise Therapy | 1 | 2012 | 434 | 0.070 |
Why?
| | Fever | 1 | 2009 | 307 | 0.070 |
Why?
| | Hypogonadism | 1 | 2008 | 88 | 0.070 |
Why?
| | Risk Assessment | 1 | 2017 | 3429 | 0.070 |
Why?
| | Immunization | 1 | 2009 | 410 | 0.070 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 251 | 0.070 |
Why?
| | Administration, Oral | 1 | 2009 | 808 | 0.070 |
Why?
| | Androgens | 1 | 2008 | 187 | 0.070 |
Why?
| | Chronic Disease | 1 | 2012 | 1784 | 0.060 |
Why?
| | Recurrence | 1 | 2009 | 1058 | 0.060 |
Why?
| | Base Sequence | 1 | 2009 | 2180 | 0.060 |
Why?
| | Infant, Newborn | 3 | 2016 | 6046 | 0.060 |
Why?
| | Estrogens | 1 | 2008 | 367 | 0.060 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1150 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2903 | 0.060 |
Why?
| | Prospective Studies | 2 | 2018 | 7583 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2677 | 0.050 |
Why?
| | Nutritive Value | 1 | 2020 | 37 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 245 | 0.040 |
Why?
| | Minerals | 1 | 2020 | 42 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 6731 | 0.040 |
Why?
| | Isoenzymes | 1 | 2020 | 304 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2975 | 0.040 |
Why?
| | Aging | 1 | 2009 | 1861 | 0.040 |
Why?
| | Physicians, Women | 1 | 2020 | 82 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 546 | 0.040 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2020 | 144 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 244 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2023 | 15564 | 0.040 |
Why?
| | Minority Groups | 1 | 2020 | 267 | 0.040 |
Why?
| | Career Choice | 1 | 2020 | 215 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2018 | 90 | 0.030 |
Why?
| | Universities | 1 | 2020 | 432 | 0.030 |
Why?
| | Social Media | 1 | 2020 | 157 | 0.030 |
Why?
| | Rickets | 1 | 2017 | 10 | 0.030 |
Why?
| | Adult | 4 | 2023 | 37616 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2020 | 337 | 0.030 |
Why?
| | Phosphorus | 1 | 2017 | 97 | 0.030 |
Why?
| | Social Support | 1 | 2020 | 615 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 820 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 387 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 359 | 0.030 |
Why?
| | Energy Intake | 1 | 2018 | 484 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5417 | 0.030 |
Why?
| | Vision Screening | 1 | 2012 | 9 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 918 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1619 | 0.020 |
Why?
| | Physicians | 1 | 2020 | 897 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5115 | 0.020 |
Why?
| | Visual Acuity | 1 | 2012 | 348 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2364 | 0.020 |
Why?
| | Endocrinology | 1 | 2009 | 79 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4018 | 0.020 |
Why?
| | Fetal Development | 1 | 2009 | 296 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 4158 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2009 | 522 | 0.010 |
Why?
| | Biomedical Research | 1 | 2009 | 689 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 13126 | 0.010 |
Why?
|
|
Ma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|